Silco Pharmaceuticals Limited announcements
108 Dhaka Stock Exchange announcements for Silco Pharmaceuticals Limited (SILCOPHL) since 2020: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2022 (19).
- The Company has requested the concerned brokerage Houses/DPs to provide a statement with the details (shareholders\' Nam
The Company has requested the concerned brokerage Houses/DPs to provide a statement with the details (shareholders\' Names, BO ID Numbers, Cilent-wise shareholding position, Gross Dividend Receivables, applicable tax rate and Net Dividend Receivables) of their Margin Loan Holders who hold company\'s share, as on the Record Date (cont.)
- Update of Information
(Continuation news of SILCOPHL): along with the name of the contact person in this connection, to the company's share/registered office on or before January 01, 2023. The Company has also requested the Merchant Banks and Depository Participants (DP) to provide their Bank Names, Account Numbers and Routing Numbers etc. (end)
The first part of this announcement is missing from the archive. - Resumption after record date
Trading of the shares of the Company will resume on 06.12.2022 after record date.
- Suspension for Record date
Trading of the shares of the Company will remain suspended on record date i.e., 05.12.2022.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 01.12.2022 to 04.12.2022. Trading of the shares will remain suspended on record date i.e., 05.12.2022.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.29 for July-September 2022 as against Tk. 0.34 for July-September 2021; NOCFPS was Tk. 0.40 for July-September 2022 as against Tk. 0.38 for July-September 2021. NAV per share was Tk. 22.28 as on September 30, 2022 and Tk. 21.95 as on June 30, 2022.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 29, 2022 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.
- The auditor of the Silco Pharmaceuticals Limited has given the \"Emphasis of matter\" paragraphs in the Auditor\'s Repor
The auditor of the Silco Pharmaceuticals Limited has given the \"Emphasis of matter\" paragraphs in the Auditor\'s Report for the year ended 30 June, 2022. Emphasis of matter: We refer to note no: 2.15(b) & 18 relevant to the implementation of sec 234 of Bangladesh Labour Act 2006 regarding Workers Profit Participation Fund (WPPF). The company discloses its status for WPPF provisioning, (Cont.)
- Emphasis of matter
(Continuation news of SILCOPHL): subsequent payment & contribution to 'Bangladesh Labour welfare Foundation' through Pay Order No: MPO/A -2869983 amounting Tk.448,157/-, dated: 31/10/2022, Mercantile Bank Limited in designated bank account by Ministry of Labour Welfare of Bangladesh. Our opinion is not modified in respect of this matter. (end)
The first part of this announcement is missing from the archive. - Update of Information
The company has requested the members to check and update their respective BO IDs, 12 digit e-TIN, Bank A/C details along with routing number to get dividend online through BEFTN system before the record date i.e. December 05, 2022.
- The Board of Directors has recommended 5\% cash dividend for all shareholders excluding Directors only for the year ende
The Board of Directors has recommended 5\% cash dividend for all shareholders excluding Directors only for the year ended June 30, 2022. The Directors hold 4,02,78,370 shares out of total 10,38,07,000 shares of the Company and the cash dividend to be payable to the General shareholders, Independent Directors and Sponsors is Tk. 3,17,64,315.00. (cont.)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (06.11.2022) following its corporate declaration. However, as per the BSEC Order No. BSEC/CMRRCD/2001-07/39 dated July 28, 2022, the floor price shall be applicable accordingly.
- Dividend Declaration
(Continuation news of SILCOPHL): Date of AGM: 10.01.2023, Time: 11:30 AM, Venue: Digital Platform. Record Date: 05.12.2022. The Company has reported EPS of Tk. 0.81, NAV per share of Tk. 21.95 and NOCFPS of Tk. 1.63 for the year ended June 30, 2022 as against Tk. 0.82, Tk. 21.85 and Tk. 2.48 respectively for the same period of the previous year. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 03, 2022 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.33 for January-March 2022 as against Tk. 0.32 for January-March 2021; EPS was Tk. 0.80 for July 2021-March 2022 as against Tk. 0.77 for July 2020-March 2021. NOCFPS was Tk. 1.31 for July 2021-March 2022 as against Tk. 1.79 for July 2020-March 2021. NAV per share was Tk. 21.98 as on March 31, 2022 and Tk. 21.85 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on May 16, 2022 at 4:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.
- Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2021 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.13 for October-December 2021 as against Tk. 0.12 for October-December 2020; EPS was Tk. 0.47 for July-December 2021 as against Tk. 0.45 for July-December 2020. NOCFPS was Tk. 0.88 for July-December 2021 as against Tk. 0.52 for July-December 2020. NAV per share was Tk. 22.24 as on December 31, 2021 and Tk. 21.85 as on June 30, 2021.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on February 15, 2022 at 4:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.